Substrates add crucial information for diagnosis, therapy, compliance and prediction. The comprehensive metabolic panel (CMP) includes eight substrates assays and is commonly ordered for a first checkup about the current status of kidneys, electrolyte and acid/base balance, as well as blood sugar.
Substrates are less expensive and available more quickly than special analytic tests1, that’s why they contribute added value to each clinical laboratory.
Roche offers the broadest Clinical Chemistry portfolio2 in the market and also maintains and invests in the current existing Clinical Chemistry tests as for example with Calcium Gen.2, which is patented and unique in the market.
Roche Clinical Chemistry analyzer - consolidation without compromise.
